The new anti-actin agent dihydrohalichondramide reveals fenestrae-forming centers in hepatic endothelial cells

BMC Cell Biol. 2002 Mar 21:3:7. doi: 10.1186/1471-2121-3-7.

Abstract

Background: Liver sinusoidal endothelial cells (LSECs) react to different anti-actin agents by increasing their number of fenestrae. A new structure related to fenestrae formation could be observed when LSECs were treated with misakinolide. In this study, we investigated the effects of two new actin-binding agents on fenestrae dynamics. High-resolution microscopy, including immunocytochemistry and a combination of fluorescence- and scanning electron microscopy was applied.

Results: Halichondramide and dihydrohalichondramide disrupt microfilaments within 10 minutes and double the number of fenestrae in 30 minutes. Dihydrohalichondramide induces fenestrae-forming centers, whereas halichondramide only revealed fenestrae-forming centers without attached rows of fenestrae with increasing diameter. Correlative microscopy showed the absence of actin filaments (F-actin) in sieve plates and fenestrae-forming centers. Comparable experiments on umbilical vein endothelial cells and bone marrow sinusoidal endothelial cells revealed cell contraction without the appearance of fenestrae or fenestrae-forming centers.

Conclusion: (I) A comparison of all anti-actin agents tested so far, revealed that the only activity that misakinolide and dihydrohalichondramide have in common is their barbed end capping activity; (II) this activity seems to slow down the process of fenestrae formation to such extent that it becomes possible to resolve fenestrae-forming centers; (III) fenestrae formation resulting from microfilament disruption is probably unique to LSECs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Actins / antagonists & inhibitors*
  • Animals
  • Cell Membrane Permeability / drug effects*
  • Dose-Response Relationship, Drug
  • Endothelium / cytology*
  • Endothelium / drug effects*
  • Endothelium / pathology
  • Endothelium / ultrastructure
  • Heterocyclic Compounds, 4 or More Rings / pharmacology*
  • Intracellular Membranes / drug effects
  • Intracellular Membranes / pathology
  • Intracellular Membranes / ultrastructure
  • Liver / cytology*
  • Liver / drug effects*
  • Liver / pathology
  • Liver / ultrastructure
  • Macrolides / pharmacology
  • Male
  • Marine Toxins / pharmacology
  • Microscopy, Electron
  • Microscopy, Electron, Scanning
  • Microscopy, Fluorescence
  • Permeability / drug effects
  • Rats
  • Rats, Wistar
  • Time Factors

Substances

  • Actins
  • Heterocyclic Compounds, 4 or More Rings
  • Macrolides
  • Marine Toxins
  • dihydrohalichondramide
  • halichondramide